Case Report: Combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease
✍ Scribed by P. González Carro; F. Pérez Roldán; O. Roncero García Escribano; R. Lafuente; M.L. Legaz Huidobro; A. Amigo Echenagusía
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 828 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0733-2459
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
FIGURE 1. MRI of the spleen. a: T1-weighted image on dynamic contrast-enhancement (axial). b: T1-weighted image on dynamic contrast-enhancement (coronal).
Our aim was to report the clinical experience with combination treatment using tacrolimus and either azathioprine (AZA) or 6-mercaptopurine (6MP) in patients with Crohn's disease (CD) perianal fistulae. The medical records of all patients with Crohn's disease perianal fistulae seen at the Mayo Clini
Tumor necrosis factor alpha (TNF-a) inhibitors improve inflammatory diseases such as Crohn's disease (CD). However, these biologicals may induce infections, neoplasms, or autoimmune diseases. Cutaneous side effects have been reported, including dermatitis, psoriasis-like rash, and vasculitis. 1 We r